London Daily

Focus on the big picture.
Monday, Aug 03, 2026

Withholding vaccine safety data ‘morally indefensible,’ medical journal says

Withholding vaccine safety data ‘morally indefensible,’ medical journal says

The British Medical Journal criticized Covid-19 vaccine manufacturers for ‘reaping vast profits’ without proper independent scrutiny

The British Medical Journal (BMJ) has urged public health regulators and pharma majors to immediately release all raw data from Covid-19 vaccine trials for independent scrutiny, arguing that “complete data transparency” was a matter of “public interest.”

Branding Big Pharma as “the least trusted industry,” a recent op-ed by BMJ editors stated that it was “morally indefensible” that this information remains inaccessible to doctors, researchers and the public, despite the global rollout of vaccines and treatments.

In the scathing editorial, the writers – senior BMJ editor Peter Doshi, former editor-in-chief Fiona Godlee and her successor Kamran Abbasi – accuse pharmaceutical companies of “reaping vast profits without adequate independent scrutiny of their scientific claims.”

"At least three of the many companies making Covid-19 vaccines have past criminal and civil settlements costing them billions of dollars. One pleaded guilty to fraud. Other companies have no pre-Covid track record."


In particular, the editorial collective calls out Pfizer, Moderna and AstraZeneca for not providing “timely access” to “anonymized individual participant data” from their clinical trials. This granular data is available to regulators like the US Food and Drug Administration (FDA), which told a judge last month to give it 75 years to publish all data relating to the Pfizer-BioNTech vaccine.

But the BMJ said Pfizer – whose trial was “funded by the company and designed, run, analyzed, and authored by Pfizer employees” – has indicated that it will not entertain data requests until May 2025, a full two years after the primary study is completed.

This lack of access to data is “consistent across vaccine manufacturers,” the editors write, noting that the industry is not “legally required” to honor requests from independent researchers.

Further, they point out that regulatory bodies like Health Canada and the European Medicines Agency do not even “receive or analyze” trial data, whereas the UK’s Medicines and Healthcare Products Regulatory Agency does not “proactively release” such info.

“The purpose of regulators is not to dance to the tune of rich global corporations and enrich them further; it is to protect the health of their populations,” they concluded.

Comments

MHogan 5 year ago
The skeptic in me believes that any negative data — safety or otherwise — released by the FDA or Pharma will have been manipulated beyond recognition from the truth.
mike 5 year ago
The pharmafia works exclusively for Dagobert Duck. People's health doesn't matter.
Maybe omicron will stop this nonsense.

Newsletter

Related Articles

0:00
0:00
Close
Triple Lock Lifts UK State Pension but Leaves a Wider Retirement Gap
Danube Drought Forces Hungary’s Paks Nuclear Plant Into Full Shutdown
Ceuta Death Toll Rises as Spain and Europe Clash Over Border Response
Cuba’s Grid Fails Again as Fuel Crisis Deepens
Nazca Lines Flight Crash Kills Thirteen as Peru Suspends Aerodiana
Modern Slavery Decisions Broaden the Al Fayed Inquiry’s Frame
FIFA’s Retreat Leaves a Larger Question Over Who Guards the Game
Two Firefighting Crew Members Die in Helicopter Collision West of Athens
Ceuta Border Surge Recasts Europe’s Migration Debate
Burnham Promises a Harder Channel Response as Crossings Test His New Government
Glasgow 2026 Commonwealth Games End With Organisers Defending Smaller Format as Sustainable Model
Reform UK Faces Labour Criticism Over Nigel Farage Leadership Return Discussions
Environment Agency Restricts River Thames Navigation as Low Water Levels Raise Concerns
UK Government Launches Free Bus Travel Scheme for Children During Summer Holidays
Chancellor Rachel Reeves Confirms October Budget Date and Plans Wider Regional Funding Shift
Prime Minister Andy Burnham Promises Tougher Action on Small Boat Crossings Amid European Migration Pressure
UK Economic Growth Forecast Raised Slightly as Inflation Expected to Remain Above Target Until 2029
National Farmers Union Warns of Food Shortage Risks as Drought and Heatwaves Damage UK Crops
Finland Deploys Commercial-Scale Thermal Batteries Using Crushed Rock to Store Renewable Grid Energy
Valued at $109 Million: F-35B Fighter Jet Crashes in Southern California
Sainsbury Agrees to Sell Argos in £120 Million Deal to Private Consortium
High Court Clears Way for Construction of Chinese Embassy at Royal Mint Court
UK Fuel Prices Climb to Multi-Month Highs as Strait of Hormuz Tensions Disrupt Oil Supplies
Severe Summer Drought and Record Heat Put UK Harvests at Risk
Prime Minister Andy Burnham Faces Labour Backbench Opposition Over Potential Support for New North Sea Oil and Gas Drilling
Bank of England Warns Inflation Will Stay Above 3% as Middle East Energy Shock Prolongs Cost-of-Living Pressures
Andy Burnham has Announces Plans to Redistribute Income Tax Revenue to English Mayors
Early-Release Scheme Faces Fresh Scrutiny as Reoffending and Prison Recalls Rise
Police Phone Checks Followed Report on Murder of MI5 Agent Inside Sinn Féin
Archbishop of Canterbury Reaffirms £100 Million Reparative Justice Fund During Ghana Visit
Charities Allege French Police Used Tear Gas Against Channel Migrants
Norwegian Teenager Convicted Over Iran-Linked Murder Plot in Britain
Christian Organisations File Charity Complaints Against Amnesty International UK
Ofgem Tightens Grid Connection Rules for New Data Centres
FTSE 100 Reaches Record High Despite Global Technology Sell-Off
Millions of UK Households Urged to Check Eligibility for Winter Energy Discount
Labour Restores Parliamentary Whips to Diane Abbott and Joani Reid
UK Supreme Court to Hear Challenge Over Palestine Action Ban
UK Commits More Than £8.4 Billion to Dreadnought Nuclear Submarine Programme
England Declares Severe Drought as Wildfire Burns Near Sizewell Nuclear Site
Bank of England Holds Interest Rates at 3.75% as Middle East Tensions Fuel Inflation Risks
Drought Status Extended Across All of Wales as Heat and Dry Weather Deepen Environmental Strain
Record-Low Danube Exposes Probable Mammoth Remains in Bulgaria
UK Business Confidence Climbs to Four-Month High
Greater Manchester Gains Expanded Powers Under Regional Funding Reforms
UK Supreme Court to Hear Appeal Over Palestine Action Terror Ban
Shell's Quarterly Profit Doubles to Nearly $10 Billion on Higher Energy Prices
UK Government Removes VAT From Household Electricity Bills
Exceptional Drought Grips Half of England as Wildfire Threatens Sizewell
Bank of England Holds Interest Rates at 3.75% as Inflation Risks Persist
×